Reasons for Terry Turner’s Shares Unload of Pinnacle Financial Partners, Inc. (PNFP)’s Stock; Shorts at SEMLER SCIENTIFIC (SMLR) Lowered By 30%

SEMLER SCIENTIFIC INC (OTCMKTS:SMLR) had a decrease of 30% in short interest. SMLR’s SI was 2,100 shares in March as released by FINRA. Its down 30% from 3,000 shares previously. With 6,000 avg volume, 0 days are for SEMLER SCIENTIFIC INC (OTCMKTS:SMLR)’s short sellers to cover SMLR’s short positions. The SI to SEMLER SCIENTIFIC INC’s float is 0.09%. The stock increased 1.15% or $0.1 during the last trading session, reaching $8.8. About 1,701 shares traded. Semler Scientific, Inc. (OTCMKTS:SMLR) has 0.00% since March 8, 2017 and is . It has underperformed by 16.70% the S&P500.

The CEO of Pinnacle Financial Partners Inc and corporation’s insider Terry Turner sold 33,065 shares of the corporation calculated based on the stock price per share of $67.7 for share. These insider shares are valued at nearly $2,237,409 USD. Currently, Mr. Terry, has ownership of 459,983 shares, which accounts for 0.59% of the Company’s market capitalization. Dated March 8, 2018, this unexpected trade by Terry Turner was revealed in the a form that was filed with the U.S. Security and Exchange Commission. It is ready for use here.

Analysts await Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) to report earnings on April, 16. They expect $1.09 earnings per share, up 31.33% or $0.26 from last year’s $0.83 per share. PNFP’s profit will be $84.29M for 15.38 P/E if the $1.09 EPS becomes a reality. After $0.97 actual earnings per share reported by Pinnacle Financial Partners, Inc. for the previous quarter, Wall Street now forecasts 12.37% EPS growth.

Among 13 analysts covering Pinnacle Financial Partners (NASDAQ:PNFP), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Pinnacle Financial Partners has $85.0 highest and $51 lowest target. $71.30’s average target is 6.30% above currents $67.075 stock price. Pinnacle Financial Partners had 39 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, February 15 by Keefe Bruyette & Woods. The stock of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) has “Buy” rating given on Thursday, January 18 by Sandler O’Neill. The company was upgraded on Friday, September 11 by Keefe Bruyette & Woods. The firm has “Mkt Perform” rating given on Thursday, October 20 by Keefe Bruyette & Woods. The stock of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) has “Buy” rating given on Thursday, January 18 by Piper Jaffray. As per Wednesday, July 22, the company rating was downgraded by Portales Partners. The firm has “Neutral” rating by Hilliard Lyons given on Friday, October 20. Piper Jaffray initiated Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) on Monday, August 24 with “Neutral” rating. On Thursday, October 20 the stock rating was downgraded by Hilliard Lyons to “Neutral”. The stock of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) has “Market Perform” rating given on Thursday, July 23 by Wood.

The stock decreased 1.29% or $0.875 during the last trading session, reaching $67.075. About 140,402 shares traded. Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) has risen 26.22% since March 8, 2017 and is uptrending. It has outperformed by 9.52% the S&P500.

Pinnacle Financial Partners, Inc. operates as a bank holding firm for Pinnacle Bank that provides various banking services and products in the United States. The company has market cap of $5.19 billion. The firm accepts various deposits, including savings, checking, interest-bearing checking, money market, and certificate of deposit accounts. It has a 24.84 P/E ratio. The Company’s loan products include commercial loans, such as equipment and working capital loans; commercial real estate loans comprising investment properties and business loans secured by real estate; and loans to individuals consisting of secured and unsecured installment and term loans and lines of credit, residential first mortgage loans, and home equity loans and lines of credit.

Since September 26, 2017, it had 0 insider purchases, and 13 selling transactions for $12.92 million activity. Sloan Thomas R also sold $989,600 worth of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) on Friday, December 15. On Friday, October 20 the insider CALLICUTT RICHARD D II sold $2.02 million. Samuel Ronald L sold $193,230 worth of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) on Tuesday, September 26. $200,333 worth of stock was sold by BURNS GREGORY L on Wednesday, February 21. TURNER M TERRY also sold $2.09 million worth of Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) on Monday, January 8. The insider Brock Charles E sold $139,900. Another trade for 17,711 shares valued at $1.19 million was made by CARPENTER HAROLD R on Friday, October 20.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.51, from 1.47 in 2017Q2. It turned negative, as 24 investors sold Pinnacle Financial Partners, Inc. shares while 66 reduced holdings. 32 funds opened positions while 100 raised stakes. 55.20 million shares or 3.94% more from 53.10 million shares in 2017Q2 were reported. Moreover, California Public Employees Retirement System has 0.03% invested in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) for 263,388 shares. Georgia-based Southeast Asset Inc has invested 0.55% in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP). Victory Mngmt Inc reported 0.18% of its portfolio in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP). Neuberger Berman Gru Ltd holds 19,381 shares. Oakbrook Invests Limited Com holds 0.03% or 5,950 shares. The Wisconsin-based State Of Wisconsin Board has invested 0.02% in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP). 1,000 were reported by Benjamin F Edwards And Incorporated. Creative Planning has invested 0% of its portfolio in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP). Cubist Systematic Strategies Lc reported 13,258 shares. Vanguard, Pennsylvania-based fund reported 5.98 million shares. Comerica Bank & Trust stated it has 88,349 shares. Envestnet Asset Management holds 0% or 14,071 shares in its portfolio. Credit Suisse Ag reported 42,145 shares. Oppenheimer Asset Mgmt reported 0.02% stake. California State Teachers Retirement Sys holds 120,028 shares or 0.02% of its portfolio.

Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company has market cap of $52.21 million. The Company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patientÂ’s vascular condition; and WellChec, a multi-test service platform that performs tests for various chronic diseases, such as respiratory disease, vascular disease, eye disease, bone disease, heart disease, neuropathy, and diabetes. It currently has negative earnings. The companyÂ’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers.